ESTRATEST Trademark

Trademark Overview

On Friday, May 15, 2020, a trademark application was filed for ESTRATEST with the United States Patent and Trademark Office. The USPTO has given the ESTRATEST trademark a serial number of 88918198. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, September 20, 2024. This trademark is owned by Method Pharmaceuticals, LLC. The ESTRATEST trademark is filed in the Pharmaceutical Products category with the following description:

Male and Female Hormone Tablet; Hormone Replacement Therapy Preparations

General Information

Serial Number88918198
Word MarkESTRATEST
Filing DateFriday, May 15, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements

Goods and ServicesMale and Female Hormone Tablet; Hormone Replacement Therapy Preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMethod Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFort Worth, TX 76244
Party NameMethod Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFort Worth, TX 76244

Trademark Events

Event DateEvent Description
Tuesday, May 19, 2020NEW APPLICATION ENTERED
Saturday, May 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 13, 2020ASSIGNED TO EXAMINER
Monday, August 24, 2020NON-FINAL ACTION WRITTEN
Monday, August 24, 2020NON-FINAL ACTION E-MAILED
Monday, August 24, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 14, 2020SUSPENSION LETTER WRITTEN
Monday, December 14, 2020LETTER OF SUSPENSION E-MAILED
Monday, December 14, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 13, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 14, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, December 14, 2021SUSPENSION INQUIRY WRITTEN
Tuesday, December 14, 2021INQUIRY TO SUSPENSION E-MAILED
Tuesday, December 14, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, June 7, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, June 16, 2022ASSIGNED TO LIE
Thursday, June 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 20, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 20, 2023SOU EXTENSION 1 FILED
Monday, March 20, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 5, 2023SOU EXTENSION 2 FILED
Tuesday, September 5, 2023SOU EXTENSION 2 GRANTED
Thursday, September 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 20, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 20, 2024SOU EXTENSION 3 FILED
Thursday, March 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU EXTENSION 4 GRANTED
Friday, September 20, 2024SOU EXTENSION 4 FILED
Friday, November 15, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords

estratest hormone therapy preparations replacement tablet female male